ReviewCurrent opinion in hematology2026

Limitations of rituximab in treating primary immune thrombocytopenia and the therapeutic potentials of alternatives.

Lingxiao Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.